|
⚲
|
| Keyboard |
| Campbell Kim
✚
|
|
|---|---|
| CIK # | 0001183827 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001183827] | |
| 4 | [0001183827] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kinex Pharmaceuticals LLC | |
| Campbell Kim |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Units · derivative
|
2021-08-03 | Grant | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2021-08-03 | Grant | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2021-05-06 | Buy | 1,750 | $4.03 | 7,052 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2021-04-05 | Buy | 8,250 | $4.42 | 36,465 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2020-06-05 | Grant | 15,000 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-02-28 | Grant | 15,000 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2018-03-27 | Grant | 18,000 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2017-06-19 | Grant | 30,000 | $0.00 |